Atlas Trials

Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand

Clinical trial NCT04764422 · COMPLETED

Trial details

NCT number
NCT04764422
Sponsor
Mahidol University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Covid-19SARS PneumoniaPneumonia, ViralCovid-19 Vaccine
Start date
2021-03-20
Primary completion
2022-09-12
Enrollment
455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.